Equities

ECO Animal Health Group PLC

EAH:LSE

ECO Animal Health Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)110.50
  • Today's Change-0.50 / -0.45%
  • Shares traded65.43k
  • 1 Year change75.40%
  • Beta0.8198
Data delayed at least 20 minutes, as of Feb 06 2026 16:07 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy1
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast

The 3 analysts offering 12 month price targets for Eco Animal Health Group Plc have a median target of 185.00, with a high estimate of 257.00 and a low estimate of 160.00. The median estimate represents a 67.42% increase from the last price of 110.50.
High132.6%257.00
Med67.4%185.00
Low44.8%160.00

Earnings history & estimates

Eco Animal Health Group Plc reported annual 2025 earnings of 3.81 per share on Jul 14, 2025.
Average growth rate+61.11%
More ▼

Revenue history & estimates

ECO Animal Health Group plc had revenues for the full year 2025 of 79.60m. This was 10.99% below the prior year's results.
Average growth rate-6.14%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.